about
Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjectsEvaluation of absolute quantitation by nonlinear regression in probe-based real-time PCRAcetabular dysplasia as an aetiological factor in development of hip osteoarthritis.Regulation of motilin release from isolated perfused pig duodenum.Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria.Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjectsIntestinal barrier homeostasis in inflammatory bowel disease.The Proteome of Ulcerative Colitis in Colon Biopsies from Adults - Optimized Sample Preparation and Comparison with Healthy Controls.Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test.Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection.Increased frequency of antral CD4 T and CD19 B cells in patients with Helicobacter pylori-related peptic ulcer disease.Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence.Alterations in antral cytokine gene expression in peptic ulcer patients during ulcer healing and after Helicobacter pylori eradication.Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.Increased expression of interleukin-21 along colorectal adenoma-carcinoma sequence and its predicating significance in patients with sporadic colorectal cancer.Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence.Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis.Acetabular dysplasia in the Sami population: a population study among Sami in north Norway.Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?Peptide-evoked release of amylase from isolated acini of the rat parotid glandPersonalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapyContribution of IL-33 to the Pathogenesis of Colorectal CancerUlcerative colitis: functional analysis of the in-depth proteomeScreening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø studyPrevention of antibiotic-associated diarrhoea by a fermented probiotic milk drinkHelicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosaDistinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequenceTissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitisMucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitisThe effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's diseaseTH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammationA sensitive method for the analysis of glutathione in porcine hepatocytes
P50
Q28595534-BE6DE28F-BE56-4AF4-9F0D-02455AFD2230Q33235423-B8AAC261-9716-471C-BF73-BD811D9DC849Q33989797-4A109934-964A-4B98-81C5-36E05D323F24Q34735840-A410FF78-4C7D-4A4A-9059-6CE3BBEF0F58Q35594292-3135ED38-F742-4A73-983F-FEA26B65CAADQ37418124-10D3E1BE-276C-4089-9A03-8644F37281B1Q38293757-061AEC20-DA29-4544-AF0C-E4AF441228C7Q38600839-B1543D48-B30A-4963-9553-9E3F84A5E214Q41475075-F62792B5-CFE4-49FC-AC88-C147B32C450DQ41711879-A78EC601-E4A6-46AD-8F68-585C04748B12Q42607873-3FD853E2-8DD9-401D-87F0-5F152C229E4CQ44207443-45088F15-2E15-4B62-B08B-AF62B9CD6AA3Q44563439-3E98D92E-EDE5-497C-9E0F-FFFD7A9691FDQ45151572-8F98160B-70E7-42FA-BDE8-085CF6391586Q45219702-5474D64F-12A1-475F-B57F-E16DCE7426D9Q46406357-2926DC3E-25DD-488F-8E54-47E2AAC34568Q46889756-AB4BEAA3-01D0-40CF-8D32-2BE11C5B6122Q47226950-0B8C01C8-CF92-4CEC-A865-C14F713C0EE5Q47832087-055949C3-7138-4BF4-876A-E984E44EF028Q50733436-DEFEA630-B007-471A-A9D2-9536A8B6B730Q51731925-6CF945E8-6077-40F7-85F8-CFD356FCDCECQ51763526-7C32538F-EAB8-45CF-B68E-576B772547D3Q51769230-779D0B1F-C60B-4588-89FE-48DB012D8BB6Q51957581-C994EBCC-115A-4732-86EB-ECF450DA2BC5Q53222922-7A19D72A-C5A2-4C07-A037-67E9E5E959B8Q53264350-8C8123ED-DBCD-458F-A89E-24589CC10120Q54393349-D7A9C341-0B64-4DEE-BCF6-D8F0EB7AE2E2Q58449155-E9D1A402-61BC-48B0-BFE6-C0324581423FQ58612293-BA4908C1-E8D2-466C-A71D-4BD792941A72Q59805320-4E45B3C0-8E4A-412B-8A01-F0D2AE06728CQ61806893-75212C1E-0496-405C-B457-88BE64EC0BAAQ64099261-94216919-9180-4DA5-94FB-BB286296D108Q79933005-27ED692C-6E28-4918-9472-40848A2D3911Q80307248-D1749400-E82A-4ACD-927D-55384027A3C2Q80501666-21A66387-C250-4B74-8A15-C5F26F5B1437Q81244424-E6B467E3-7589-4283-BA97-AE6295C06A59Q83836747-D1BD49DC-EAA1-4087-96A0-DB36EA498797Q84724010-5C6985FD-9159-499E-A5B9-865DD86C4034Q84980225-4231BB17-3CFF-49D0-B165-2F7F0521D38DQ85673486-3DE1ADB0-83FE-421B-9003-9AC34FA592BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rasmus Goll
@ast
Rasmus Goll
@en
Rasmus Goll
@es
Rasmus Goll
@nl
Rasmus Goll
@sl
type
label
Rasmus Goll
@ast
Rasmus Goll
@en
Rasmus Goll
@es
Rasmus Goll
@nl
Rasmus Goll
@sl
prefLabel
Rasmus Goll
@ast
Rasmus Goll
@en
Rasmus Goll
@es
Rasmus Goll
@nl
Rasmus Goll
@sl
P106
P1153
6603072976
P21
P31
P496
0000-0003-4375-0509